Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Hackett

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The World Journal of Men'S Health|September 14, 2018
Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile FunctionGeoffrey Hackett, Nigel Cole, Akhilesh Mulay, et al.
BJU International|September 15, 2018
Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factorsGeoffrey Hackett, Nigel Cole, Akhilesh Mulay, et al.
The Journal of Sexual Medicine|April 5, 2013
Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetesGeoffrey Hackett, Nigel Cole, Mithun Bhartia, et al.
The Journal of Sexual Medicine|December 7, 2013
Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST studyGeoffrey Hackett, Nigel Cole, Mithun Bhartia, et al.
BJU International|April 29, 2016
Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled studyGeoffrey Hackett, Nigel Cole, Atif Saghir, et al.
International Journal of Clinical Practice|March 21, 2017
UK policy statements on testosterone deficiencyGeoffrey Hackett, Michael Kirby, David Edwards, et al.
Androgens: Clinical Research and Therapeutics|October 6, 2022
Examining Male Predominance of Severe COVID-19 Outcomes: A Systematic ReviewDavid K Twitchell, Michael B Christensen, Geoffrey Hackett, et al.
BJU International|June 13, 2012
Can simvastatin improve erectile function and health-related quality of life in men aged ≥40 years with erectile dysfunction? Results of the Erectile Dysfunction and Statins Trial [ISRCTN66772971]Daksha Trivedi, Michael Kirby, David M Wellsted, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 10, 2018
A New Perspective on the Nitrate-Phosphodiesterase Type 5 Inhibitor InteractionRobert A Kloner, Paul Goggin, Irwin Goldstein, et al.
The World Journal of Men'S Health|March 7, 2024
Testosterone Replacement Therapy: Effects on Blood Pressure in Hypogonadal MenGeoffrey Hackett, Amar Mann, Ahmad Haider, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The World Journal of Men'S Health|September 14, 2018
Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile FunctionGeoffrey Hackett, Nigel Cole, Akhilesh Mulay, et al.
BJU International|September 15, 2018
Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factorsGeoffrey Hackett, Nigel Cole, Akhilesh Mulay, et al.
The Journal of Sexual Medicine|April 5, 2013
Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetesGeoffrey Hackett, Nigel Cole, Mithun Bhartia, et al.
The Journal of Sexual Medicine|December 7, 2013
Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST studyGeoffrey Hackett, Nigel Cole, Mithun Bhartia, et al.
BJU International|April 29, 2016
Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled studyGeoffrey Hackett, Nigel Cole, Atif Saghir, et al.
International Journal of Clinical Practice|March 21, 2017
UK policy statements on testosterone deficiencyGeoffrey Hackett, Michael Kirby, David Edwards, et al.
Androgens: Clinical Research and Therapeutics|October 6, 2022
Examining Male Predominance of Severe COVID-19 Outcomes: A Systematic ReviewDavid K Twitchell, Michael B Christensen, Geoffrey Hackett, et al.
BJU International|June 13, 2012
Can simvastatin improve erectile function and health-related quality of life in men aged ≥40 years with erectile dysfunction? Results of the Erectile Dysfunction and Statins Trial [ISRCTN66772971]Daksha Trivedi, Michael Kirby, David M Wellsted, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 10, 2018
A New Perspective on the Nitrate-Phosphodiesterase Type 5 Inhibitor InteractionRobert A Kloner, Paul Goggin, Irwin Goldstein, et al.
The World Journal of Men'S Health|March 7, 2024
Testosterone Replacement Therapy: Effects on Blood Pressure in Hypogonadal MenGeoffrey Hackett, Amar Mann, Ahmad Haider, et al.
Pageof 4